Frontier Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-119,628
| Closed | -$3.47M | – | 295 |
|
|
2025
Q1 | $3.47M | Sell |
119,628
-3,732
| -3% | -$108K | 0.04% | 266 |
|
|
2024
Q4 | $4.58M | Sell |
123,360
-259
| -0.2% | -$9.62K | 0.04% | 256 |
|
|
2024
Q3 | $6M | Sell |
123,619
-1,149
| -0.9% | -$55.8K | 0.06% | 240 |
|
|
2024
Q2 | $4.99M | Sell |
124,768
-1,195
| -0.9% | -$47.8K | 0.05% | 250 |
|
|
2024
Q1 | $5.53M | Sell |
125,963
-1,574
| -1% | -$69.1K | 0.05% | 244 |
|
|
2023
Q4 | $7.89M | Buy |
127,537
+211
| +0.2% | +$13.1K | 0.08% | 211 |
|
|
2023
Q3 | $5.86M | Sell |
127,326
-18,570
| -13% | -$854K | 0.06% | 224 |
|
|
2023
Q2 | $8.38M | Sell |
145,896
-41,164
| -22% | -$2.37M | 0.08% | 210 |
|
|
2023
Q1 | $7.01M | Sell |
187,060
-16,911
| -8% | -$634K | 0.07% | 213 |
|
|
2022
Q4 | $5.72M | Sell |
203,971
-602
| -0.3% | -$16.9K | 0.06% | 226 |
|
|
2022
Q3 | $5.75M | Sell |
204,573
-1,090
| -0.5% | -$30.6K | 0.07% | 226 |
|
|
2022
Q2 | $7.16M | Sell |
205,663
-45,609
| -18% | -$1.59M | 0.08% | 227 |
|
|
2022
Q1 | $9.02M | Sell |
251,272
-936
| -0.4% | -$33.6K | 0.08% | 220 |
|
|
2021
Q4 | $5.87M | Sell |
252,208
-3,605
| -1% | -$84K | 0.05% | 248 |
|
|
2021
Q3 | $4.86M | Buy |
255,813
+70,834
| +38% | +$1.35M | 0.04% | 258 |
|
|
2021
Q2 | $3.73M | Buy |
+184,979
| New | +$3.73M | 0.03% | 276 |
|